Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06091189 · ClinicalTrials.gov registry record · Early Phase 1

Internalized Stress in Relation to Alcohol Consumption

A Early Phase 1 study, sponsored by Texas Tech University.

Terminated
Registry status
Early Phase 1
Development phase
165
Enrollment target

NCT06091189 is a Early Phase 1 study that was terminated before completion, run by Texas Tech University. The registered enrollment target is 165 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06091189, a Early Phase 1 study, was terminated before completion, sponsored by Texas Tech University.

TERMINATED
Registry status
Early Phase 1
Development phase
165 participants
Enrollment target

Study Summary

The proposed study uses an experimental design to establish causal support for the role of internalized stress, pertaining to uncertainty with regard to one's sexual orientation, in contributing to heavy drinking behavior. Following exposure to internalized sexual stigma, physiological and psychological stress responses are expected to increase alcohol consumption in adults who are uncertain about their sexual orientation, especially among females, and following consumption, the physiological effects of ethanol and beliefs about the effects of alcohol are expected to alter relations between exposure to sexual stigma and the alleviation of psychological distress. Showing that physiological stress responses, whether driven by the pharmacological effects of ethanol or expectancies regarding its effects, can account for known alcohol-use disparities, particularly in bisexual/bi+ communities, would contribute a great deal to knowledge on the biology of addiction and inform subsequent interventions that seek to regulate stress reactivity.

Interventions

  • DRUG Ethanol
  • BEHAVIORAL Relevant Trier Social Stressor Test (TSST)
  • BEHAVIORAL Placebo Trier Social Stressor Test (TSST)
  • BEHAVIORAL Placebo Beverage
  • BEHAVIORAL Irrelevant Trier Social Stressor Test (TSST)

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2024-02-12
Est. Completion 2025-02-28
Phase Early Phase 1

Sponsor

Texas Tech University

69 total trials

What the Registry Record Tells You About NCT06091189

The ClinicalTrials.gov registry entry for NCT06091189 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Ethanol is the first listed.

NCT06091189 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06091189 about?

NCT06091189 is a clinical study titled "Internalized Stress in Relation to Alcohol Consumption". The proposed study uses an experimental design to establish causal support for the role of internalized stress, pertaining to uncertainty with regard to one's sexual orientation, in contributing to heavy drinking behavior. Following exposure to internalized sexual stigma, physiological and psycholog...

What is the current status of trial NCT06091189?

This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 165 participants. The study started on 2024-02-12. Estimated completion is 2025-02-28.

What interventions are being tested in trial NCT06091189?

The interventions under investigation include: Ethanol (DRUG), Relevant Trier Social Stressor Test (TSST) (BEHAVIORAL), Placebo Trier Social Stressor Test (TSST) (BEHAVIORAL), Placebo Beverage (BEHAVIORAL), Irrelevant Trier Social Stressor Test (TSST) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06091189?

This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.